NCT06453928View on ClinicalTrials.gov

Starting Technology in At Risk Type 1 Diabetes Study

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 5, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2027

Conditions
Diabetes Mellitus, Type 1
Interventions
DEVICE

Hybrid Closed Loop Insulin Pump System

Patients will be started on an automated insulin delivery system.

Trial Locations (2)

90404

RECRUITING

UCLA, Santa Monica

90502

RECRUITING

Harbor-UCLA Medical Center, Torrance

All Listed Sponsors
collaborator

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of California, Los Angeles

OTHER